000 01395 a2200385 4500
005 20250516111903.0
264 0 _c20130131
008 201301s 0 0 eng d
022 _a1873-2623
024 7 _a10.1016/j.transproceed.2012.07.079
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlamo, J M
245 0 0 _aAntitumor efficacy of mammalian target of rapamycin inhibitor therapy in liver transplant recipients with oncological disease: a case-control study.
_h[electronic resource]
260 _bTransplantation proceedings
_cSep 2012
300 _a2089-92 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCarcinoma, Hepatocellular
_xsurgery
650 0 4 _aCase-Control Studies
650 0 4 _aCholangiocarcinoma
_xsurgery
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xpharmacology
650 0 4 _aLiver Neoplasms
_xsurgery
650 0 4 _aLiver Transplantation
650 0 4 _aTOR Serine-Threonine Kinases
_xantagonists & inhibitors
700 1 _aBernal, C
700 1 _aMarín, L M
700 1 _aSuárez, G
700 1 _aSerrano, J
700 1 _aBarrera, L
700 1 _aSousa, J M
700 1 _aPadillo, F J
700 1 _aGómez-Bravo, M A
773 0 _tTransplantation proceedings
_gvol. 44
_gno. 7
_gp. 2089-92
856 4 0 _uhttps://doi.org/10.1016/j.transproceed.2012.07.079
_zAvailable from publisher's website
999 _c22102025
_d22102025